Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d -galactosamine/lipopolysaccharide in mice

Bibliographic Data

ID21095770
AuthorsXiangying Zhang (0009-0004-7878-8560, Beijing Institute of Neurosurgery), Jianbo Ding (Beijing YouAn Hospital), Chunyan Gou (Capital Medical University), Tao Wen (0000-0003-0675-0163, Capital Medical University), Li Li (0000-0001-9700-9682, Beijing YouAn Hospital), Xiaojun Wang (0009-0006-0120-7275, Capital Medical University), Huasheng Yang (0000-0003-2767-8623, Capital Medical University), Dan Liu (0009-0003-1264-0160, Beijing YouAn Hospital), Jinli Lou (Beijing YouAn Hospital), Dexi Chen (0000-0002-6896-6640, Capital Medical University), Feng Ren (0000-0002-0641-8948, Beijing Institute of Neurosurgery, corresponding author), Xiuhui Li (0009-0006-5287-3016, Beijing YouAn Hospital, corresponding author)
Year2017
Volume201
Pages108-116
Publication date2017-04-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2016.11.007
PMID27833028
OpenAlexW2554426864
LanguageEN
Citations received1
References cited39

Our findings demonstrated that the Qingchangligan formula exerts a protective effect against the pathophysiology of ALF, especially in regulating liver inflammation, and provide a rationale for using the Qingchangligan formula as a potential therapeutic strategy to ameliorate ALF

Alanine transaminase · Biology · Galactosamine · Hepatocyte · In vitro · In vivo · Inflammation · Intraperitoneal injection · Lipopolysaccharide · Liver injury · Chemistry · Drug-Induced Hepatotoxicity and Protection · Ginger and Zingiberaceae research · Liver Disease and Transplantation · Medicine · Biochemistry · Immunology · Internal Medicine · Pharmacology

Tools

Open DOISci-HubOpen Access